×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
OKYO – okyo pharma limited - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
OKYO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/19
08:10 pm
okyo
OKYO Pharma Announces Director Acquires Shares [Yahoo! Finance]
Low
Report
OKYO Pharma Announces Director Acquires Shares [Yahoo! Finance]
3/19
12:00 pm
okyo
OKYO Pharma Announces Chairman and Founder Acquires Shares
Medium
Report
OKYO Pharma Announces Chairman and Founder Acquires Shares
3/19
10:00 am
okyo
OKYO Pharma Announces Director Acquires Shares
Low
Report
OKYO Pharma Announces Director Acquires Shares
3/19
07:00 am
okyo
OKYO Pharma Announces Chief Development Officer and Director Acquires Shares
Low
Report
OKYO Pharma Announces Chief Development Officer and Director Acquires Shares
3/18
09:18 am
okyo
OKYO Pharma reports improved quality-of-life outcomes in mid-stage eye pain trial [Yahoo! Finance]
Medium
Report
OKYO Pharma reports improved quality-of-life outcomes in mid-stage eye pain trial [Yahoo! Finance]
3/18
07:40 am
okyo
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain [Yahoo! Finance]
Low
Report
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain [Yahoo! Finance]
3/18
07:00 am
okyo
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
Medium
Report
OKYO Pharma Reports New Phase 2 Data Demonstrating Meaningful Improvements in Patient-Reported Quality of Life Outcomes with Urcosimod in Neuropathic Corneal Pain
2/23
12:14 pm
okyo
OKYO Pharma to present first-in-human urcosimod data at ARVO 2026 [Yahoo! Finance]
Low
Report
OKYO Pharma to present first-in-human urcosimod data at ARVO 2026 [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
12:00 pm
okyo
Form 6-K OKYO Pharma Ltd For: Mar 19
Low
Report
Form 6-K OKYO Pharma Ltd For: Mar 19
3/19
10:00 am
okyo
Form 6-K OKYO Pharma Ltd For: Mar 19
Medium
Report
Form 6-K OKYO Pharma Ltd For: Mar 19
3/19
07:00 am
okyo
Form 6-K OKYO Pharma Ltd For: Mar 19
Low
Report
Form 6-K OKYO Pharma Ltd For: Mar 19
3/18
08:38 pm
okyo
Form 3 OKYO Pharma Ltd For: Mar 18 Filed by: JACOB GARY S
Low
Report
Form 3 OKYO Pharma Ltd For: Mar 18 Filed by: JACOB GARY S
3/18
08:36 pm
okyo
Form 3 OKYO Pharma Ltd For: Mar 18 Filed by: CERRONE GABRIELE M
Low
Report
Form 3 OKYO Pharma Ltd For: Mar 18 Filed by: CERRONE GABRIELE M
3/18
07:58 am
okyo
Form 6-K OKYO Pharma Ltd For: Mar 18
Medium
Report
Form 6-K OKYO Pharma Ltd For: Mar 18
3/12
04:18 pm
okyo
Form 6-K OKYO Pharma Ltd For: Mar 12
Low
Report
Form 6-K OKYO Pharma Ltd For: Mar 12
2/23
11:00 am
okyo
Form 6-K OKYO Pharma Ltd For: Feb 23
Low
Report
Form 6-K OKYO Pharma Ltd For: Feb 23
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: